| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9154454 | American Heart Journal | 2005 | 8 Pages |
Abstract
Based on the available data sets, clinical trials, reviews, and registry data, the evidence suggests that LMWH compared to UFH may be a safe and effective agent in patients with MPHVs. Future large-scale, randomized trials are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Niranjan MD, Samuel Z. MD, FACC, Uri MD, FACC, Richard A. DO, FACC, James B. PharmD, John A. MD, FACC, Sarah A. PharmD, FCCP, Alexander G.G. MD, FRCP, FRCP(C), FACC, Gideon MD, Allan L. MD, FRCP(C), FACC,